Literature DB >> 12091159

Studies of the early bactericidal activity of new drugs for tuberculosis: a help or a hindrance to antituberculosis drug development?

Richard J O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12091159     DOI： 10.1164/rccm.2205007

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.

Authors:  Tawanda Gumbo; Arnold Louie; Mark R Deziel; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.

Authors:  Shashikant Srivastava; Sandirai Musuka; Carleton Sherman; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

3.  Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum.

Authors:  Nino Mdivani; Haijing Li; Maka Akhalaia; Medea Gegia; Leila Goginashvili; Douglas S Kernodle; George Khechinashvili; Yi-Wei Tang
Journal:  Clin Chem       Date:  2009-07-02       Impact factor: 8.327

4.  A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs.

Authors:  Divan Aristo Burger; Robert Schall
Journal:  J Biopharm Stat       Date:  2014-10-16       Impact factor: 1.051
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.